215 related articles for article (PubMed ID: 29541389)
21. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
23. The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells.
Siqueira PB; Rodrigues MMS; Amorim ĹSS; Rodrigues JA; Oliveira MS; Fonseca AS; Pires BRB; Mencalha AL
Braz J Med Biol Res; 2024; 57():e13250. PubMed ID: 38808886
[TBL] [Abstract][Full Text] [Related]
24. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
[TBL] [Abstract][Full Text] [Related]
25. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
26. APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.
Shah F; Goossens E; Atallah NM; Grimard M; Kelley MR; Fishel ML
Mol Oncol; 2017 Dec; 11(12):1711-1732. PubMed ID: 28922540
[TBL] [Abstract][Full Text] [Related]
27. APE1/Ref-1 as a Novel Target for Retinal Diseases.
Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
[TBL] [Abstract][Full Text] [Related]
28. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
29. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.
Choi S; Joo HK; Jeon BH
Chonnam Med J; 2016 May; 52(2):75-80. PubMed ID: 27231670
[TBL] [Abstract][Full Text] [Related]
31. Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.
Mantha AK; Dhiman M; Taglialatela G; Perez-Polo RJ; Mitra S
J Neurosci Res; 2012 Jun; 90(6):1230-9. PubMed ID: 22488727
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
33. APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.
Wang YT; Tzeng DW; Wang CY; Hong JY; Yang JL
Toxicology; 2013 Mar; 305():120-9. PubMed ID: 23370007
[TBL] [Abstract][Full Text] [Related]
34. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.
Kelley MR; Georgiadis MM; Fishel ML
Curr Mol Pharmacol; 2012 Jan; 5(1):36-53. PubMed ID: 22122463
[TBL] [Abstract][Full Text] [Related]
35. APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
Sahakian L; Robinson AM; Sahakian L; Stavely R; Kelley MR; Nurgali K
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002251
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
[TBL] [Abstract][Full Text] [Related]
37. APE1/Ref-1: versatility in progress.
Jeon BH; Irani K
Antioxid Redox Signal; 2009 Mar; 11(3):571-4. PubMed ID: 18715142
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).
Nyland RL; Luo M; Kelley MR; Borch RF
J Med Chem; 2010 Feb; 53(3):1200-10. PubMed ID: 20067291
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1.
Sui J; Li M; Qian C; Wang S; Cheng Y; Chen BP; Wang D
Drug Des Devel Ther; 2014; 8():2147-60. PubMed ID: 25395832
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.
Xie JY; Li MX; Xiang DB; Mou JH; Qing Y; Zeng LL; Yang ZZ; Guan W; Wang D
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):385-93. PubMed ID: 21030352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
